Company / Inventory
BeOne Medicines Ltd. Inventory History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$608.2M
FY2025
5-year range
$242.6M / $608.2M
FY2021-FY2025
Trend
+22.9%
vs FY2024
Sector context
#21 of 105
Health Care
What the data says
BeOne Medicines Ltd.'s inventory of $608M is higher than 80% of companies in the Health Care sector (FY2025). Inventory has increased for 8 consecutive years, from $11M in FY2017 to $608M in FY2025.
Based on SEC 10-K filings.
$608M in FY2025 with a 5-year CAGR of +46.8%. Top quartile in the Health Care sector.
Improved from $416M to $608M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +29.2%
- 5-Year CAGR
- +46.8%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 105This company $608.2M Sector average $885.3M
▼
-31.3% below sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s inventory has grown for 8 consecutive years.
- 5-year CAGR of +46.8%, indicating consistent growth.
- In FY2025, inventory increased 22.9% year-over-year.
- Ranks #21 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $608.2M | +22.9% |
| FY2024 | $495.0M | +19.0% |
| FY2023 | $416.1M | +47.4% |
| FY2022 | $282.3M | +16.4% |
| FY2021 | $242.6M | +171.7% |
| FY2020 | $89.3M | +212.7% |
| FY2019 | $28.6M | +75.8% |
| FY2018 | $16.2M | +48.6% |
| FY2017 | $10.9M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026